INVESTOR RELATIONS

Stock price

NYSEVAR

$3.2B
FY 2019 REVENUES
10%
REVENUES GROWTH IN FY 2019
9%
ONCOLOGY ORDERS GROWTH IN FY 2019
5%
NON-GAAP EPS ¹ GROWTH IN FY 2019

$3.2B
FY 2019 REVENUES
10%
REVENUES GROWTH IN FY 2019
9%
ONCOLOGY ORDERS GROWTH IN FY 2019
5%
NON-GAAP EPS ¹ GROWTH IN FY 2019

Press Releases

Aug 2, 2020

Varian Reports Results for Third Quarter of Fiscal Year 2020

Third Quarter 2020 Summary Operating performance reflects a full quarter of COVID-19 impact across all geographies Oncology Systems gross orders down 14% in dollars and in constant currency in the...

Aug 2, 2020

Varian to Combine with Siemens Healthineers in $16.4 Billion All-Cash Transaction

Varian (NYSE: VAR) today announced that it has entered into a definitive agreement to combine with Siemens Healthineers AG (Frankfurt: SHL) in an all-cash transaction valued at $16.4 billion on a...

Jul 17, 2020

Varian Announces Third Quarter Fiscal Year 2020 Earnings Release Date

Varian (NYSE: VAR) today announced its third quarter fiscal year 2020 earnings release date. The Company will report results for the third quarter of fiscal year 2020 after market close on...

Jul 6, 2020

Varian Wins "Best After-Sales Service Award for Radiotherapy Products" in China For Third Year In A Row

Varian (NYSE: VAR) today announced it received the "Best After-Sales Service Award for Radiotherapy Products" in the 2019 Chinese Medical Devices Industry Data and After-Sales Service Survey for...

View all press releases

Upcoming Events

No events to display

View all events

Past Events

Third Quarter FY2020 Earnings Results Conference Call

Wednesday, August 5, 2020

1:30pm PDT

Canceled Third Quarter Conference Call in Light of Pending Transaction with Siemens Healthineers

Goldman Sachs Global Virtual Healthcare Conference

Tuesday, June 9, 2020

11:20am EDT